Pharmacoeconomic Impact and Transplant Outcome Associated to Carmustine (BCNU) Substitution with Bendamustine (Be) in the Conditioning Regimen Prior to Autologous Stem Cell Transplantation for Lymphoma Treatment

被引：0
|
作者：
Boisjoly, Josie-Anne [1 ]
Bouchard, Philippe [2 ]
Ahmad, Imran [3 ]
Bambace, Nadia M. [3 ]
Bernard, Lea [3 ]
Cohen, Sandra [3 ]
Delisle, Jean-Sebastien [3 ]
Kiss, Thomas L. [4 ]
Roy, Denis-Claude [3 ]
Sauvageau, Guy [3 ]
Roy, Jean [3 ]
Lachance, Silvy [3 ]
机构：
[1] Ctr Hosp Univ Sherbrooke, Div Hematol Oncol, Sherbrooke, PQ, Canada
[2] Univ Montreal, Hop Maisonneuve Rosemont, Pharm, Montreal, PQ, Canada
[3] Univ Montreal, Hop Maisonneuve Rosemont, Div Hematol Oncol & Transplantat, Montreal, PQ, Canada
[4] Univ Montreal, Hop Maisonneuve Rosemont, Hematol Oncol & Hematopoiet Cell Transplantat, Montreal, PQ, Canada
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2018年 / 24卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
155
引用
收藏
页码：S129 / S130
页数：2
相关论文
共 50 条
  • [21] TEAM (THIOTEPA, ETOPOSIDE, CYTARABINE, MELPHALAN) AS CONDITIONING REGIMEN FOR LYMPHOMA TREATMENT WITH AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION
    Carella, A. M.
    Palumbo, G.
    Merla, E.
    Ferrara, F.
    Greco, M.
    Dell'Olio, M.
    Scalzulli, P.
    Pisapia, G.
    Mazza, P.
    Guarini, A.
    Iacobazzi, A.
    Musto, P.
    Capalbo, S.
    Cascavilla, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 66 - 66
  • [22] Bendamustine-based conditioning prior to autologous stem cell transplantation is associated with high rate of febrile neutropenia and higher mortality
    Lucijanic, Marko
    Prka, Zeljko
    Jaksic, Ozren
    Mitrovic, Zdravko
    Vrkljan, Anamarija
    Pejsa, Vlatko
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (02) : E42 - E43
  • [23] Modified Conditioning Regimen with Idarubicin Prior to Autologous Hematopoietic Stem Cell Transplantation in B-Cell Non-Hodgkin Lymphoma
    Tian, Chen
    Li, Yueyang
    You, M. James
    Zhao, Zhigang
    Zhang, Yizhuo
    Wang, Yafei
    BLOOD, 2019, 134
  • [24] Busulfan, cyclophosphamide, etoposide is not superior to carmustine, etoposide, cytarabine, mephalan conditioning prior to autologous stem cell transplantation in patients with Hodgkin's lymphoma and is associated with increased toxicity
    Salem, G.
    Dunavin, N.
    Wei, L.
    Elder, P.
    Penza, S.
    Blum, K.
    Porcu, P.
    Baiocchi, R.
    Jones, J.
    Flynn, J.
    Andritsos, L.
    Devine, S. M.
    Christian, B.
    Efebera, Y.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S84 - S85
  • [25] Fotemustine, etoposide, cytarabine, and cyclophosphamide (FEAC) conditioning regimen for autologous stem cell transplantation in lymphoma
    Lin, Meng
    Wu, Xiaolong
    Zhang, Lei
    Li, Ling
    Wang, Xinhua
    Fu, Xiaorui
    Sun, Zhenchang
    Zhang, Xudong
    Zhu, Linan
    Yu, Hui
    Chang, Yu
    Nan, Feifei
    Yan, Jiaqin
    Zhou, Zhiyuan
    Shi, Cunzhen
    Zhang, Mingzhi
    Li, Xin
    LEUKEMIA & LYMPHOMA, 2023, 64 (03) : 605 - 612
  • [26] BeEAC conditioning regimen for autologous hematopoietic stem-cell transplantation in malignant lymphoma patients
    Dubinina, Yulia
    Sarzhevskiy, Vladislav
    Samoylova, Anastasiya
    Mochkin, Nikita
    Melnichenko, Vladimir
    Kolesnikova, Dina
    Bogatyrev, Vladimir
    Smirnova, Elena
    Ivanova, Diana
    Bannikova, Anna
    BONE MARROW TRANSPLANTATION, 2018, 53 : 260 - 261
  • [27] Modified BuCy is an alternative conditioning regimen for lymphoma patients undergoing autologous stem cell transplantation
    Huang, Haiwen
    Zhang, Lihong
    Jiang, Yibin
    Liu, Shuo
    Jin, Zhengming
    Chen, Jia
    Xiao, Xiaofang
    Ruan, Jia
    Zhang, Xinyou
    Wu, Depei
    ANNALS OF HEMATOLOGY, 2019, 98 (05) : 1259 - 1266
  • [28] Modified BEAM as conditioning regimen for lymphoma patients undergoing autologous hematopoietic stem cell transplantation
    Galieni, P.
    Troiani, E.
    Bigazzi, C.
    Mazzotta, S.
    Ruggieri, M.
    Pezzoni, V.
    Dalsass, A.
    Mestichelli, F.
    Caraffa, P.
    Travaglini, F.
    Ferretti, S.
    Angelini, M.
    Angelini, S.
    Falcioni, S.
    BONE MARROW TRANSPLANTATION, 2018, 53 (01) : 91 - 93
  • [29] Modified BEAM as conditioning regimen for lymphoma patients undergoing autologous hematopoietic stem cell transplantation
    P Galieni
    E Troiani
    C Bigazzi
    S Mazzotta
    M Ruggieri
    V Pezzoni
    A Dalsass
    F Mestichelli
    P Caraffa
    F Travaglini
    S Ferretti
    M Angelini
    S Angelini
    S Falcioni
    Bone Marrow Transplantation, 2018, 53 : 91 - 93
  • [30] Comparison of Beam and Team as Conditioning Regimen for Lymphoma Patients undergoing Autologous Stem Cell Transplantation
    Atesoglu, Elif Birtas
    Deveci, Burak
    Dora, Imran
    Eren, Cigdem
    Celik, Suat
    Kusdemir, Gokhan
    Bayrak, Esra
    Karadogan, Ihsan
    Gulbas, Zafer
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 302 - 302
12345